
CRWD · Nasdaq
The supplied consensus is Buy across 44 analysts. Its target figures are internally inconsistent: the stated low and high are both $520 while the mean is $250, so they do not establish a coherent target range or cluster. Other supplied aggregations report averages from $238.54 (ChartMill) to $309.89 (Public.com), while Benzinga identifies Mizuho’s $520 target as the highest named target; the evidence does not identify a named least-bullish analyst. No analyst revisions during this week are reported. The available target dispersion therefore reflects sharply different valuation views, but the supplied snippets do not provide enough detail to attribute the disagreement to specific assumptions.
| Firm | Analyst | Rating | Price Target | Upside | Date | Source |
|---|---|---|---|---|---|---|
| Mizuho | — | $520 | +112.3% | Apr 27, 2026 | Open the report this row came from | |
| Mizuho | — | $520 | +112.3% | Apr 27, 2026 |